Late breaking trials of 2016 in coronary artery disease: Commentary covering SCAI, ACC, TCT, EuroPCR, ESC, and AHA

Arnold H Seto; Payam Dehghani; Binita Shah; Saif Anwaruddin; Jordan Safirstein; Jennifer A Tremmel

doi:10.1002/ccd.26940

Late breaking trials of 2016 in coronary artery disease: Commentary covering SCAI, ACC, TCT, EuroPCR, ESC, and AHA

Catheter Cardiovasc Interv. 2017 May;89(6):1028-1034. doi: 10.1002/ccd.26940. Epub 2017 Mar 9.

Authors

Arnold H Seto¹, Payam Dehghani², Binita Shah³, Saif Anwaruddin⁴, Jordan Safirstein⁵, Jennifer A Tremmel⁶

Affiliations

¹ Division of Cardiology, Department of Medicine, Long Beach Veterans Affairs Medical Center, Long Beach, California.
² Prairie Vascular Research Network, University of Saskatchewan, Regina, Saskatchewan, Canada.
³ Veterans Affairs New York Harbor Health Care System, New York University School of Medicine, New York, New York.
⁴ Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
⁵ Department of Cardiology, The Gagnon Cardiovascular Institute at the Morristown Memorial Hospital, Morristown, New Jersey.
⁶ Department of Medicine (Cardiovascular), Stanford University Medical Center, Stanford, California.

PMID: 28276150
DOI: 10.1002/ccd.26940

Abstract

The SCAI Publications Committee and Emerging Leadership Mentorship (ELM) Fellows concisely summarize and provide context on the most important coronary trials presented at large international meetings in 2016, including SCAI, ACC, TCT, EuroPCR, ESC, and AHA. The intent is to allow quick assimilation of trial results into interventional practice, and enable busy interventional cardiologists to stay up to date. © 2017 Wiley Periodicals, Inc.

Publication types

Congress

MeSH terms

Clinical Trials as Topic*
Coronary Artery Disease / diagnostic imaging
Coronary Artery Disease / mortality
Coronary Artery Disease / therapy*
Diffusion of Innovation
Humans
Treatment Outcome

Grants and funding

IK2 CX001074/CX/CSRD VA/United States